128 related articles for article (PubMed ID: 18257688)
1. Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland.
Dehò L; Walwema R; Cappelletti A; Sukati H; Sibandze D; Almaviva M; Buttò S; Ensoli B; Galli M; Balotta C
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):323-5. PubMed ID: 18257688
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
5. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
6. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
Arora SK; Gupta S; Toor JS; Singla A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
[TBL] [Abstract][Full Text] [Related]
9. The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados.
Gittens MV; Roth WW; Roach T; Stringer HG; Pieniazek D; Bond VC; Levett PN
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):313-9. PubMed ID: 12816080
[TBL] [Abstract][Full Text] [Related]
10. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
11. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
[TBL] [Abstract][Full Text] [Related]
12. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
Balakrishnan P; Kumarasamy N; Kantor R; Solomon S; Vidya S; Mayer KH; Newstein M; Thyagarajan SP; Katzenstein D; Ramratnam B
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):301-5. PubMed ID: 15943572
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
[TBL] [Abstract][Full Text] [Related]
15. Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India.
Azam M; Malik A; Rizvi M; Rai A
J Infect Dev Ctries; 2014 Jan; 8(1):79-85. PubMed ID: 24423716
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project).
Bruzzone B; Saladini F; Sticchi L; Mayinda Mboungou FA; Barresi R; Caligiuri P; Calzi A; Zazzi M; Icardi G; Viscoli C; Bisio F
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):837-40. PubMed ID: 25970260
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
[TBL] [Abstract][Full Text] [Related]
19. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
